Products
Platform
Research
Market
Learn
Compare ITI Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.35 | 1.93 |
NAV | ₹16.25 | ₹432.37 |
Fund Started | 18 Oct 2021 | 04 Jun 1999 |
Fund Size | ₹235.68 Cr | ₹4026.55 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 3 months. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.35
1.93
NAV
₹16.25
₹432.37
Fund Started
18 Oct 2021
04 Jun 1999
Fund Size
₹235.68 Cr
₹4026.55 Cr
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | -1.32% | 6.02% |
3 Year | 21.46% | 26.60% |
5 Year | - | 20.53% |
1 Year
-1.32%
6.02%
3 Year
21.46%
26.60%
5 Year
-
20.53%
Holding Analysis
Equity | 98.71% | 97.60% |
Cash | 1.29% | 2.33% |
Equity
98.71%
97.60%
Cash
1.29%
2.33%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.93% |
Divi's Laboratories Ltd. | 8.68% |
Max Healthcare Institute Ltd. | 6.12% |
Apollo Hospitals Enterprise Ltd. | 5.66% |
Cohance Lifesciences Ltd. | 4.66% |
Torrent Pharmaceuticals Ltd. | 4.58% |
Aurobindo Pharma Ltd. | 3.66% |
Fortis Healthcare Ltd. | 3.51% |
Lupin Ltd. | 3.46% |
Aster DM Healthcare Ltd. | 3.19% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.44% |
Divi's Laboratories Ltd. | 7.21% |
Max Healthcare Institute Ltd. | 6.50% |
Cipla Ltd. | 4.63% |
Lonza Group Ag | 4.09% |
Lupin Ltd. | 4.02% |
Gland Pharma Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.57% |
Acutaas Chemicals Ltd. | 3.30% |
Krishna Institute of Medical Sciences Ltd | 3.26% |
Fund Manager
Name | Dhimant Shah | Tanmaya Desai |
Start Date | 29 May 2023 | 27 Jun 2011 |
Name
Dhimant Shah
Tanmaya Desai
Start Date
29 May 2023
27 Jun 2011
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 18 Oct 2021 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
18 Oct 2021
04 Jun 1999
